• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

PARP Inhibitor Market – Increasing approvals of innovative drugs molecules | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline Plc., Pfizer, Inc

August 3rd, 2022 Coherent Market Insights Releases

Overview:

PARP inhibitors help in treating disease like cancer, as they inhibit PARP (poly ADP ribose polymerase) enzyme. Various types of cancers are dependent on PARP enzymes, so making these enzymes an effective method for treating cancer. PARP inhibitors can be used for treating subset of ovarian cancer. These inhibitors also assist in restoring DNA damaged due to anti-cancer drugs and UV radiation. The PARP inhibitors block the enzymes which are required for repairing breaks in single strands of the DNA molecule.

Global PARP inhibitor market, was forecast to be valued at US$ 887.7 Mn in 2018, over the forecast period.

Click Here to Get a Sample Copy (Exclusive Offer: UPTO 30% Discount for A Limited Time) @ https://www.coherentmarketinsights.com/insight/request-sample/3037

Drivers:

Rising incidences of cancer is estimated to increase demand for drugs, which is anticipated to fuel growth of the global PARP inhibitor market over the forecast period. For instance, researchers from University of Montreal Hospital Research Centre, have developed a combination therapy for treating ovarian cancer in June 2019.

Furthermore, chemotherapy along with PARP inhibitors can be used for minimizing cancer cells proliferation. Growing R&D activities in cancer treatment sector is estimated to offer productive opportunities to the manufacturers for commercializing new drugs in the PARP inhibitor market.

Breakpoint Therapeutics is a spinoff company formed by Evotec in July 2019, for developing cancer treating drugs, and they raised around US$ 36 Million. These drugs work by blocking the DNA repair mechanism resulting in resisting cancer.

Moreover, growing support from the government for spreading awareness is estimated to boost growth of the global PARP inhibitor market growth during the forecast period. For instance, Australian government declared that they are investing US$ 1.6 Million in Ovarian Cancer Australia. The main aim of the project is to give support and care to the patients suffering from ovarian cancer in Australia. As per the reports by government of Australia, almost 400 individuals with a risk of ovarian cancer can benefit from this project.

Major players are carrying out acquisitions and collaborations for promoting R&D in the ovarian and breast cancer treatment. Clovis Oncology, Inc. initiated a collaboration with Alkermes plc., in February 2019, for Alkerme’s ALKS 4230 investigating interleukin-2 variant immunotherapy along with lucitanib and rucaparib.

Key Takeaways:

  • The global PARP inhibitor market is estimated to exhibit a CAGR of 32.4% during the forecast period, due to rising incidences of cancer. The 2018 statistics of World Health Organization mentioned cancer as the second leading reason of death worldwide. It was estimated that around 9.6 million individuals lost their lives to cancer in 2018.
  • The Olaparib (Lynparza) segment, among drug types in the global PARP inhibitor market is anticipated to boost growth over the forecast period, due to rising product approvals in emerging and developed countries globally. For instance, Merck and AstraZeneca plc., gained approval from the Health Canada for Lynparza in May 2019. Lynparza is used for maintenance treatment in patients suffering from fallopian tube cancer, peritoneal cancer or BRCA-mutated high-grade epithelial ovarian cancer.
  • The ovarian cancer segment, among application, in the global PARP inhibitor market is estimated to drive growth over the forecast period, due to the increased application of PARP inhibitors for the treating ovarian cancer.
  • The hospital pharmacies segment, among distribution channel in the global PARP inhibitor market is estimated to augment growth over the forecast period, due to availability of relevant medications at the pharmacies in hospitals.

Key players:

  • Key players active in the global PARP Inhibitor market are Ono Pharmaceutical Co., LTD., Merck KGaA, GlaxoSmithKline plc., Jiangsu Hengrui Medicine Co., Ltd, Pfizer, Inc., Karyopharm Therapeutics Inc., AstraZeneca Plc., Sierra Oncology, Inc., AbbVie Inc., Repare Therapeutics Inc., Clovis Oncology Inc., Genentech, Inc. and Bristol – Myers Squibb.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3037

The Study Objectives are:

✔ A comprehensive insight into key players operating in the PARP Inhibitor Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 PARP Inhibitor Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: PARP Inhibitor Industry Impact

Chapter 2 Global PARP Inhibitor Competition by Types, Applications, and Top Regions and Countries
2.1 Global PARP Inhibitor (Volume and Value) by Type
2.3 Global PARP Inhibitor (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global PARP Inhibitor Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America PARP Inhibitor Market Analysis
Chapter 6 East Asia PARP Inhibitor Market Analysis
Chapter 7 Europe PARP Inhibitor Market Analysis
Chapter 8 South Asia PARP Inhibitor Market Analysis
Chapter 9 Southeast Asia PARP Inhibitor Market Analysis
Chapter 10 Middle East PARP Inhibitor Market Analysis
Chapter 11 Africa PARP Inhibitor Market Analysis
Chapter 12 Oceania PARP Inhibitor Market Analysis
Chapter 13 South America PARP Inhibitor Market Analysis
Chapter 14 Company Profiles and Key Figures in PARP Inhibitor Business
Chapter 15 Global PARP Inhibitor Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/3037

Customization of the Report

Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email